Feline Haemotropic Mycoplasmosis Explained

Haemobartonellosis, now more accurately termed feline hemotropic mycoplasmosis (FHM), represents serious infectious disease caused by microscopic parasitic bacteria that attach directly surface red blood cells, triggering immune-mediated destruction blood cells potentially leading life-threatening hemolytic anaemia. The condition caused primarily Mycoplasma haemofelis and related haemotropic Mycoplasma species—small gram-negative bacteria that parasitise erythrocytes, causing body's immune system recognise infected cells abnormal and systematically destroy them, resulting reduced oxygen-carrying capacity potentially severe anaemia requiring emergency veterinary intervention. Disease ranges dramatically mild infection with few symptoms life-threatening anaemia demanding urgent blood transfusions and intensive supportive care, depending on which bacterial strain infects cat and individual cat's immune competence overall health. Historically called feline infectious anaemia (FIA) or haemobartonellosis, modern genetic sequencing reclassified causative organisms Mycoplasma genus, leading to preferred current terminology feline hemotropic mycoplasmosis. The disease particularly common outdoor cats, male cats, cats involved territorial fighting, and those co-infected feline leukaemia virus (FeLV) or feline immunodeficiency virus (FIV), though any cat exposed infected cats parasites potentially become infected. Transmission routes remain somewhat unclear and debated veterinary community, though fleas and tick bites strongly implicated, as are direct bite wounds from fighting and blood transfusions from infected donors. Early diagnosis and prompt aggressive treatment substantially improve recovery prognosis; however, even treated cats often become long-term carriers capable transmitting infection other cats, remaining potential silent infection sources particularly stress-prone situations.

This comprehensive guide explains what haemobartonellosis is and how bacteria cause disease, identifies high-risk cat populations, describes detailed clinical symptoms owners should recognise, outlines diagnostic procedures veterinarians use distinguish this condition from other causes anaemia, discusses available treatment options including antibiotics and supportive care, covers recovery timeline and carrier status, addresses prevention strategies, and explains when immediate veterinary care essential.

Understanding Haemobartonellosis

What Is Haemobartonellosis?

FHM infectious disease caused by parasitic bacteria Mycoplasma species attaching red blood cell surface; potentially causes severe hemolytic anaemia.

• Current terminology: Feline hemotropic mycoplasmosis (FHM); previously called feline infectious anaemia (FIA) haemobartonellosis
• Causative bacteria: Mycoplasma haemofelis (most pathogenic), Candidatus Mycoplasma haemominutum, Candidatus Mycoplasma turicensis
• Bacterial characteristics: Small gram-negative bacteria lacking cell walls; epierythrocytic parasites attaching red blood cell surface rather than inside cells
• Mechanism: Immune system recognises infected red blood cells abnormal and destroys them, leading hemolytic anaemia
• Worldwide distribution: Found globally; prevalence varies geographically
• Severity variable: Ranges asymptomatic carrier state mild clinical disease severe life-threatening anaemia

The Three Main Species

• Mycoplasma haemofelis: Most pathogenic species; causes moderate severe hemolytic anaemia; responsible acute severe infections; mortality up 33 percent untreated cases
• Candidatus Mycoplasma haemominutum: Most common species cat populations worldwide; alone has not been associated disease immunocompetent cats but may cause anaemia FeLV-infected cats
• Candidatus Mycoplasma turicensis: Less common; variable pathogenicity; genetic diversity exists within this species

Transmission and Risk Factors

How Haemobartonellosis Spreads

Transmission routes incompletely understood; fleas implicated primary vectors.

• Flea bites: Most commonly implicated transmission route
• Tick bites: Less common transmission route
• Bite wounds: Direct transmission during fighting between cats
• Blood transfusions: Transmission infected donor blood
• Mother-to-kitten: Rare transplacental transmission possible
• Uncertain mechanism: Exact transmission pathways remain incompletely understood

High-Risk Populations

• Outdoor cats: Greater exposure parasites fighting
• Male cats: Seven times more likely infected than females
• Territorial fighters: Cats involved frequent fighting increased risk
• Flea-infested cats: Infestation increases transmission probability
• FeLV-infected cats: Co-infection associated more severe disease
• FIV-infected cats: Immunocompromised cats higher risk severe illness
• Older male non-pedigree cats: Age sex coat type increase risk
• Any cat: Healthy indoor cats also become infected though less common

Clinical Signs and Symptoms

Anaemia-Related Symptoms

Clinical signs depend severity anaemia.

• Pale gums: Most obvious early sign
• Weakness: General muscle weakness
• Lethargy: Lack energy, decreased activity
• Loss appetite: Reduced interest food
• Rapid breathing: Increased respiratory rate compensate reduced oxygen
• Increased heart rate: Tachycardia compensate anaemia
• Depression: Overall mood change, withdrawn behaviour
• Reduced activity: Reluctance play exercise
• Dehydration: Dry mucous membranes
• Weight loss: Progressive body condition loss

Severe Anaemia Signs

• Jaundice: Yellow discolouration gums skin, eyes (indicates liver involvement)
• Collapse: Sudden loss consciousness
• Difficulty breathing: Severe respiratory distress
• Extreme weakness: Unable stand move normally
• Fever: Elevated body temperature

Asymptomatic Carriers

• Many infected cats: Show few or no symptoms despite infection
• Carrier status: May remain asymptomatic yet capable transmitting infection
• Undetected infections: Many cases go undiagnosed
• Silent threat: Carriers unknowingly spread disease other cats

How Haemobartonellosis Causes Anaemia

Three-stage process leads red blood cell destruction.

• Bacterial attachment: Mycoplasma species attach red blood cell surface
• Immune recognition: Immune system identifies infected cells abnormal foreign
• Cell destruction: Spleen and immune system actively destroy infected erythrocytes
• Reduced oxygen: Progressive cell loss reduces oxygen-carrying capacity
• Bone marrow response: Bone marrow attempts replace destroyed cells through increased production
• Anaemia development: Destruction exceeds replacement, severe anaemia develops
• Organ stress: Reduced oxygen delivery stresses heart, brain, other vital organs

Diagnosis of Haemobartonellosis

Clinical Assessment

• Medical history: Outdoor exposure, fighting, fleas, contact infected cats
• Physical examination: Assess pallor mucous membranes, fever, overall condition
• Symptom pattern: Recognising characteristic signs anaemia

Laboratory Tests

• Complete blood count (CBC): Reveals reduced red blood cell count, haemoglobin levels, packed cell volume
• Blood smear examination: Microscopic inspection blood looking for bacteria attached red blood cells
• PCR testing: Polymerase chain reaction detects bacterial DNA; most accurate sensitive method; gold standard diagnosis
• Blood chemistry profile: Assesses liver kidney function, overall health status
• FeLV and FIV testing: Essential rule out concurrent infections altering disease severity and prognosis
• Urinalysis: Evaluates overall kidney function and general health
• Serial blood samples: Bacteria presence sometimes cyclic; multiple samples different times day may be necessary

Diagnostic Challenges

• Cyclic parasitaemia: Bacteria may not always visible blood smears
• Carrier detection: Low-level infections easily missed without PCR
• PCR preferred: Superior sensitivity specificity compared traditional methods

Treatment of Haemobartonellosis

Antibiotic Treatment

Primary treatment; eliminates suppresses bacterial infection.

• Doxycycline: Standard first-line treatment; 5–10 mg/kg orally every 12–24 hours 14–21 days
• Enrofloxacin: Effective alternative fluoroquinolone antibiotic
• Marbofloxacin: Alternative fluoroquinolone; sometimes used sequential combination doxycycline
• Pradofloxacin: Another fluoroquinolone option
• Sequential therapy: Using doxycycline followed quinolone may achieve complete bacteremia clearance
• Side effects: Tetracyclines can cause oesophagitis, GI disease, retinal damage; fluoroquinolones have own risk profiles
• Treatment duration: Full course essential; incomplete treatment allows relapse
• Carrier status: Antibiotics may not completely eliminate infection; cats often remain carriers

Immune Suppression

• Corticosteroids: Prednisolone or similar reduce immune-mediated destruction red blood cells
• When indicated: Used severe anaemia or when immune-mediated destruction particularly severe
• Dosing: Typically 2 mg/kg daily; adjusted based response
• Combined therapy: Works alongside antibiotics addressing both infection and immune response

Blood Transfusion

• Severe anaemia: Life-threatening anaemia requires packed red blood cell transfusion
• Cross-matching: Necessary prevent transfusion reactions
• Temporary measure: Stabilises oxygen delivery while treatment takes effect
• Consideration: Transfused cells can become infected bacteria; requires careful monitoring

Supportive Care

• Fluid therapy: Intravenous fluids for dehydrated critically ill cats
• Nutritional support: Highly palatable food encouraging appetite recovery
• Pain management: Comfort care supportive treatment
• Rest: Quiet environment reducing stress

Recovery and Prognosis

Recovery Timeline

• Initial response: Most cats begin improving within 24 hours appropriate treatment
• Clinical improvement: Symptoms typically resolve within days weeks
• Full recovery: Complete anaemia resolution may take weeks
• Variable timeline: Individual cats recover different rates depending severity underlying health
• Follow-up testing: Blood tests usually required monitor progress

Long-Term Outcomes

• Carrier state: Many treated cats remain long-term carriers shedding bacteria
• Relapses possible: Some cats experience recurrent clinical disease particularly during stress illness
• Mortality: M. haemofelis can cause death up 33 percent untreated infected cats
• Treatment success: Early diagnosis prompt treatment significantly improve survival rates
• Protective immunity: After initial infection, some protective immunity develops preventing repeat M. haemofelis infection

Prevention of Haemobartonellosis

Risk Reduction Strategies

• Flea control: Year-round effective flea prevention most important preventive measure
• Tick prevention: Regular tick prevention where appropriate
• Indoor housing: Keeping cats indoors reduces exposure parasites fighting
• Neutering: Reduces territorial fighting behaviour
• Prompt wound care: Immediate treatment bite wounds prevents infection
• Transfusion screening: Testing blood donor cats preventing transmission transfusion
• Regular check-ups: Routine veterinary examinations detect early disease
• Parasite testing: Screening cats infections before introducing new household

When to Seek Veterinary Care

• Pale gums: Any paleness mucous membranes
• Sudden weakness: Acute onset lethargy weakness
• Collapse: Loss consciousness immediate emergency
• Rapid breathing: Increased respiratory rate distress
• Loss appetite: Refusal food lasting over 24 hours
• Jaundice: Yellow discolouration gums eyes skin
• Severe lethargy: Cat extremely unresponsive weak
• Fever: Elevated body temperature

This guide based research from VCA Animal Hospitals, National Kitten Coalition, Canadian Veterinary Medical Association (CVMA), ABCD Cats Vets guidelines, Merck Veterinary Manual, peer-reviewed journals PubMed, PMC. Epierythrocytic definition: organisms living on outer surface cells. Haemolytic anaemia definition: anaemia resulting from red blood cell destruction lysis rather than decreased production. Mycoplasma characteristics: lack cell walls (unlike other bacteria); minimal genomes containing only essential genes; fastidious growth requirements; difficult culture outside host. Splenectomy significance: spleen removes infected erythrocytes; cats lacking spleen may show more severe clinical signs. Bone marrow response: normal bone marrow can increase production ten-fold attempt compensate destruction; if destruction exceeds maximum production capacity, severe anaemia results. Cyclic parasitaemia: bacteria presence blood varies cyclically; low parasitaemia periods explain negative blood smears despite active infection. FeLV interaction: FeLV increases M. haemominutum pathogenicity even though alone not associated disease; FeLV co-infection produces more severe anaemia. Cross-matching procedure: testing donor recipient blood compatibility preventing transfusion reactions. Reticulocyte count: measuring immature red blood cells; elevated levels indicate bone marrow responding increase production. Glucocorticoid mechanism: suppress T-cell mediated erythrophagocytosis (destruction infected red cells) while allowing continued antibiotic efficacy against bacteria. Marbofloxacin advantage: fluoroquinolone with excellent tissue penetration; particularly effective penetrating protected sites where bacteria may persist.